Current role
Elissa Cote
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Elissa Cote
Vistagen Therapeutics, Inc. reported in an 8-K filed June 25, 2025 that Elissa Cote was appointed Chief Corporate Development Officer, effective June 23, 2025.
“On June 25, 2025, Vistagen Therapeutics, Inc. (the "Company") announced the appointment of Ms. Elissa Cote as the Company's Chief Corporate Development Officer, effective June 23, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Vistagen Therapeutics, Inc. (VTGN)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vistagen Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Shawn K. Singh CEO, Board Member
- Cynthia Anderson CFO
- Nick B. Tressler CFO, Chief Accounting Officer
- Joshua Prince COO
- Joshua S. Prince COO
- Reid G. Adler General Counsel
- Douglas J. Williamson, M.D. Board Member
- Joanne Curley, Ph.D. Board Member
- Margaret M. FitzPatrick Board Member
- Mary L. Rotunno Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.